Arcturus Therapeutics Holdings (ARCT) Current Leases: 2019-2025
Historic Current Leases for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to $4.1 million.
- Arcturus Therapeutics Holdings' Current Leases rose 20.00% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 20.00%. This contributed to the annual value of $3.6 million for FY2024, which is 17.57% down from last year.
- Latest data reveals that Arcturus Therapeutics Holdings reported Current Leases of $4.1 million as of Q3 2025, which was up 2.26% from $4.0 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Current Leases registered a high of $4.3 million during Q4 2023, and its lowest value of $1.4 million during Q2 2021.
- Moreover, its 3-year median value for Current Leases was $4.0 million (2025), whereas its average is $4.0 million.
- Its Current Leases has fluctuated over the past 5 years, first spiked by 155.09% in 2022, then decreased by 18.21% in 2024.
- Arcturus Therapeutics Holdings' Current Leases (Quarterly) stood at $1.5 million in 2021, then surged by 152.70% to $3.9 million in 2022, then rose by 10.94% to $4.3 million in 2023, then dropped by 17.57% to $3.6 million in 2024, then increased by 20.00% to $4.1 million in 2025.
- Its Current Leases was $4.1 million in Q3 2025, compared to $4.0 million in Q2 2025 and $3.7 million in Q1 2025.